Amalgamated Bank’s Pulse Biosciences PLSE Stock Holding History

Amalgamated Bank’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-557	Closed	-$8K	–	2511
2025 Q4	$8K	Sell	557 -75	-12%	-$1.17K	﹤0.01%	2535
2025 Q3	$11K	Hold	632	–	–	﹤0.01%	2428
2025 Q2	$10K	Hold	632	–	–	﹤0.01%	2442
2025 Q1	$10K	Buy	632 +87	+16%	+$1.62K	﹤0.01%	2381
2024 Q4	$9K	Hold	545	–	–	﹤0.01%	2493
2024 Q3	$10K	Hold	545	–	–	﹤0.01%	2470
2024 Q2	$6K	Hold	545	–	–	﹤0.01%	2710
2024 Q1	$5K	Sell	545 -1,089	-67%	-$10K	﹤0.01%	2730
2023 Q4	$20K	Sell	1,634 -162	-9%	-$1.12K	﹤0.01%	2654
2023 Q3	$7K	Hold	1,796	–	–	﹤0.01%	2949
2023 Q2	$13K	Buy	+1,796	New	+$11.5K	﹤0.01%	2913
2022 Q2	–	Sell	-2,273	Closed	-$11K	–	3161
2022 Q1	$11K	Buy	+2,273	New	+$18.6K	﹤0.01%	2944

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Amalgamated Bank's PLSE Position: Q1 2026 in Review

Amalgamated Bank sold out of Pulse Biosciences (PLSE) in Q1 2026, closing a stake of 557 shares — an estimated $8K sold.

Amalgamated Bank first reported a position in PLSE in Q1 2022 and held it in 12 quarters. The position peaked at $20K in Q4 2023. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

Amalgamated Bank reported no remaining Pulse Biosciences position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 557 Pulse Biosciences shares in Q1 2026, an estimated $8K.
Amalgamated Bank first reported a position in Pulse Biosciences in Q1 2022 and held it in 12 quarters.
Amalgamated Bank's Pulse Biosciences position peaked at $20K in Q4 2023.
96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.